Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers

Hepatology

Volumn 62, Issue 5, 2015, Pages 1444-1455

  Bannas, Peter ^a,b   Kramer, Harald ^a,c   Hernando, Diego ^a   Agni, Rashmi ^a   Cunningham, Ashley M ^a   Mandal, Rakesh ^a   Motosugi, Utaroh ^a   Sharma, Samir D ^a   Munoz del Rio, Alejandro ^a   Fernandez, Luis ^d   Reeder, Scott B ^a,d,e  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; EX VIVO STUDY; FAT CONTENT; FATTY LIVER; FEMALE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER HISTOLOGY; LIVER LOBE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGAN DONOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGIST; VALIDATION STUDY; AGED; LIVER; METABOLISM; NONALCOHOLIC FATTY LIVER; PATHOLOGY; PROCEDURES;

ADULT; AGED; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; TRIGLYCERIDES;

EID: 84945180317     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28012     Document Type: Article

References (47)

1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-1395.
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
3. Schwimmer JB. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. Semin Liver Dis 2007;27:312-318.
4. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann Med 2005;37:347-356.
5. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-121.
6. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
7. Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006;43:682-689.
8. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009;104:861-867.
9. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:521-533, viii.
10. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3-20.
11. Smedile A, Bugianesi E. Steatosis and hepatocellular carcinoma risk. Eur Rev Med Pharmacol Sci 2005;9:291-293.
12. Choi SS, Diehl AM. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr Opin Lipidol 2008;19:295-300.
13. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-2023.
14. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
15. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
16. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898-1906.
17. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457.
18. El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009;250:691-697.
19. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
20. Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 2012;36:1011-1014.
21. Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009;251:67-76.
22. Meisamy S, Hines CD, Hamilton G, Sirlin CB, McKenzie CA, Yu H, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011;258:767-775.
23. Hines CD, Frydrychowicz A, Hamilton G, Tudorascu DL, Vigen KK, Yu H, et al. T(1) independent, T(2)(*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 2011;33:873-881.
24. Zhong X, Nickel MD, Kannengiesser SA, Dale BM, Kiefer B, Bashir MR. Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magn Reson Med 2014;72:1353-1365.
25. Kuhn JP, Hernando D, Mensel B, Kruger PC, Ittermann T, Mayerle J, et al. Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging 2014;39:1494-1501.
26. Yokoo T, Shiehmorteza M, Hamilton G, Wolfson T, Schroeder ME, Middleton MS, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011;258:749-759.
27. Kuhn JP, Hernando D, Munoz del Rio A, Evert M, Kannengiesser S, Volzke H, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012;265:133-142.
28. Hwang I, Lee JM, Lee KB, Yoon JH, Kiefer B, Han JK, et al. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and H MR spectroscopy. Radiology 2014:130863.
29. Noworolski SM, Lam MM, Merriman RB, Ferrell L, Qayyum A. Liver steatosis: concordance of MR imaging and MR spectroscopic data with histologic grade. Radiology 2012;264:88-96.
30. Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013;58:1930-1940.
31. Hines CD, Yu H, Shimakawa A, McKenzie CA, Warner TF, Brittain JH, et al. Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology 2010;254:119-128.
32. Hines CD, Agni R, Roen C, Rowland I, Hernando D, Bultman E, et al. Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse. J Magn Reson Imaging 2012;35:844-851.
33. Hernando D, Kellman P, Haldar JP, Liang ZP. Robust water/fat separation in the presence of large field inhomogeneities using a graph cut algorithm. Magn Reson Med 2010;63:79-90.
34. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008;60:1122-1134.
35. Yu H, McKenzie CA, Shimakawa A, Vu AT, Brau AC, Beatty PJ, et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 2007;26:1153-1161.
36. Hernando D, Hines CD, Yu H, Reeder SB. Addressing phase errors in fat-water imaging using a mixed magnitude/complex fitting method. Magn Reson Med 2012;67:638-644.
37. Hernando D, Sharma SD, Kramer H, Reeder SB. On the confounding effect of temperature on chemical shift-encoded fat quantification. Magn Reson Med 2014;72:464-470.
38. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 2007;58:354-364.
39. Reeder SB, Wen Z, Yu H, Pineda AR, Gold GE, Markl M, et al. Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn Reson Med 2004;51:35-45.
40. Hamilton G, Middleton MS, Bydder M, Yokoo T, Schwimmer JB, Kono Y, et al. Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 2009;30:145-152.
41. Soher BJ, Wyatt C, Reeder SB, MacFall JR. Noninvasive temperature mapping with MRI using chemical shift water-fat separation. Magn Reson Med 2010;63:1238-1246.
42. Hernando D, Artz N, Hamilton G, Roldan A, Reeder SB. Fully automated processing of multi-echo spectroscopy data for liver fat quantification. In: Proceedings of the 22nd Annual Meeting of the International Society of Magnetic Resonance in Medicine, May 10-16, 2014; Milan, Italy; 2884.
43. Reeder SB, Robson PM, Yu H, Shimakawa A, Hines CD, McKenzie CA, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 2009;29:1332-1339.
44. Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015;274:416-425.
45. Reeder SB, Hines CD, Yu H, McKenzie CA, Brittain JH. Relationship between proton-density fat-fraction, true fat concentration for in vivo fat quantification with magnetic resonance imaging. In: Proceedings of the 19th Annual Meeting of the International Society of Magnetic Resonance in Medicine, May 7-13, 2011; Montreal, Canada; Abstract 805.
46. Reeder SB, Hines CD, Yu H, McKenzie CA, Brittain JH. On the definition of fat-fraction for in vivo fat quantification with magnetic resonance imaging. In: Proceedings of the 17th Annual Meeting of the International Society of Magnetic Resonance in Medicine, April 18-24, 2009; Honolulu, Hawaii; Abstract 207.
47. Hu HLY, Nagy T, Goran M, Nayak K. Quantification of absolute fat mass: a validation study between chemical-shift MRI and chemical analysis. In: Proceedings of the 20th Annual Meeting of the International Society of Magnetic Resonance in Medicine, May 5-11, 2012; Melbourne, Australia; Abstract 1266.